SERUM LPAI LIPOPROTEIN PARTICLES IN DIABETIC-PATIENTS WITH AND WITHOUT RENAL LESIONS OF DIFFERENT GRADES

被引:0
|
作者
PEYNET, J
GUILLAUSSEAU, PJ
LEGRAND, A
ALTMAN, JJ
FLOURIE, F
CHANSON, P
POUPON, J
NGUYEN, M
WARNET, A
LUBETZKI, J
ROUSSELET, F
机构
[1] HOP LARIBOISIERE,SERV MED B,F-75010 PARIS,FRANCE
[2] AURA,F-75013 PARIS,FRANCE
来源
DIABETES & METABOLISM | 1993年 / 19卷 / 04期
关键词
TYPE 1 DIABETES MELLITUS; TYPE 2 DIABETES MELLITUS; MICROALBUMINURIA; CHRONIC RENAL FAILURE; APOLIPOPROTEINS; PLASMA LIPIDS; LPAI LIPOPROTEIN PARTICLE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Among high density lipoprotein particles, LpAI particles which contain apolipoprotein Al alone, appear to be involved in cholesterol transport from peripheral tissues to the liver. The aim of this cross-sectional study was to examine serum LpAI particle concentrations in Type 1 and Type 2 diabetic patients with renal lesions of differing grades, in comparison with normal controls and with nondiabetic patients presenting with chronic renal failure. LpAI concentrations and LpAI-to-apo Al ratios were increased in Type 1 diabetic patients with normal albumin excretion. In Type 1 and in Type 2 diabetic patients with increased urinary albumin excretion, LpAI concentrations and LpAI-to-apo Al ratios were found to be not different from those of normal controls. In diabetic and in nondiabetic patients with chronic renal failure, LpAI concentrations were decreased. These abnormalities may contribute to the development of macrovascular complications.
引用
收藏
页码:355 / 360
页数:6
相关论文
共 50 条
  • [1] LIPOPROTEIN(A) IN DIABETIC-PATIENTS WITH AND WITHOUT CHRONIC-RENAL-FAILURE
    GUILLAUSSEAU, PJ
    PEYNET, J
    CHANSON, P
    LEGRAND, A
    ALTMAN, JJ
    POUPON, J
    NGUYEN, M
    ROUSSELET, F
    LUBETZKI, J
    DIABETES CARE, 1992, 15 (08) : 976 - 979
  • [2] SERUM-HIGH-DENSITY LIPOPROTEIN IN DIABETIC-PATIENTS
    LOPESVIRELLA, MF
    COLWELL, JA
    LANCET, 1976, 1 (7972): : 1291 - 1292
  • [3] SERUM HIGH-DENSITY LIPOPROTEIN IN DIABETIC-PATIENTS
    LOPESVIRELLA, MFL
    STONE, PG
    COLWELL, JA
    DIABETOLOGIA, 1977, 13 (04) : 285 - 291
  • [4] LIPID PEROXIDE LEVELS OF SERUM LIPOPROTEIN FRACTIONS OF DIABETIC-PATIENTS
    NISHIGAKI, I
    HAGIHARA, M
    TSUNEKAWA, H
    MASEKI, M
    YAGI, K
    BIOCHEMICAL MEDICINE, 1981, 25 (03): : 373 - 378
  • [5] SERUM HIGH-DENSITY LIPOPROTEIN (HDL) IN DIABETIC-PATIENTS
    LOPESVIRELLA, MF
    STONE, P
    COLWELL, JA
    CLINICAL RESEARCH, 1976, 24 (04): : A581 - A581
  • [6] Serum lipoprotein (a) levels in patients with diabetic foot lesions
    Ünlühizarci, K
    Muhtaroglu, S
    Kabak, S
    Bayram, F
    Kelestimur, F
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (02) : 119 - 123
  • [7] EFFECTS OF NICERITROL ON ELEVATED SERUM-LIPOPROTEIN LP(A) LEVELS IN DIABETIC-PATIENTS WITH OR WITHOUT OVERT PROTEINURIA
    KAZUMI, T
    YOSHINO, G
    MAEDA, T
    HOZUMI, T
    ISHIDA, Y
    MAEDA, E
    NAKA, Y
    YOSHIDA, M
    KASUGA, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (05): : 546 - 551
  • [8] BIOLOGICAL FACTORS AFFECTING CONCENTRATIONS OF SERUM LPAI LIPOPROTEIN PARTICLES IN SERUM, AND DETERMINATION OF REFERENCE LIMITS
    STEINMETZ, J
    CHOUKAIFE, A
    VISVIKIS, S
    HENNY, J
    SIEST, G
    CLINICAL CHEMISTRY, 1990, 36 (04) : 677 - 680
  • [9] LIPOPROTEIN(A) IN TYPE-1 DIABETIC-PATIENTS WITH RENAL-DISEASE
    GROOP, PH
    VIBERTI, GC
    ELLIOTT, TG
    FRIEDMAN, R
    MACKIE, A
    EHNHOLM, C
    JAUHIAINEN, M
    TASKINEN, MR
    DIABETIC MEDICINE, 1994, 11 (10) : 961 - 967
  • [10] CHANGES IN LIPOPROTEIN METABOLISM AND GROWTH OF FIBROBLASTS FROM DIABETIC-PATIENTS RELATED TO DIABETIC SERUM
    KOSCHINSKY, T
    BUNTING, CE
    SCHWIPPERT, B
    GRIES, FA
    DIABETOLOGIA, 1978, 15 (03) : 247 - 247